MeSH Review:
HIV Long Terminal Repeat
- Activation of human B-MYB by cyclins. Sala, A., Kundu, M., Casella, I., Engelhard, A., Calabretta, B., Grasso, L., Paggi, M.G., Giordano, A., Watson, R.J., Khalili, K., Peschle, C. Proc. Natl. Acad. Sci. U.S.A. (1997)
- Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar, M., Duan, L., Bagasra, O., Pomerantz, R.J. Gene Ther. (1996)
- Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. Rullas, J., Bermejo, M., García-Pérez, J., Beltán, M., González, N., Hezareh, M., Brown, S.J., Alcamí, J. Antivir. Ther. (Lond.) (2004)
- Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. Sancho, R., de la Vega, L., Macho, A., Appendino, G., Di Marzo, V., Muñoz, E. J. Immunol. (2005)
- Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat. Equils, O., Madak, Z., Liu, C., Michelsen, K.S., Bulut, Y., Lu, D. J. Immunol. (2004)
- Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. Equils, O., Faure, E., Thomas, L., Bulut, Y., Trushin, S., Arditi, M. J. Immunol. (2001)
- Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. Rusnati, M., Coltrini, D., Oreste, P., Zoppetti, G., Albini, A., Noonan, D., d'Adda di Fagagna, F., Giacca, M., Presta, M. J. Biol. Chem. (1997)
- Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell. Niikura, M., Dornadula, G., Zhang, H., Mukhtar, M., Lingxun, D., Khalili, K., Bagasra, O., Pomerantz, R.J. Oncogene (1996)
- Hydroxyurea inhibits the transactivation of the HIV-long-terminal repeat (LTR) promoter. Calzado, M.A., MacHo, A., Lucena, C., Muñoz, E. Clin. Exp. Immunol. (2000)
- Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Márquez, N., Sancho, R., Bedoya, L.M., Alcamí, J., López-Pérez, J.L., Feliciano, A.S., Fiebich, B.L., Muñoz, E. Antiviral Res. (2005)
- Human GM-CSF induces HIV-1 LTR by multiple signalling pathways. Watanabe, S., Murakami, T., Nakamura, T., Morimoto, C., Arai, K. Biochimie (2002)
- Activation of transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat by the vasoactive intestinal peptide (VIP). Gilles, A., Miquelis, A., Luis, J., Faure, E. Ital. J. Biochem. (1998)